Efavirenz
In Stock•Starting at $9 for 10 mg•Purity ≥ 98%
| CAS No. | 154598-52-4 |
|---|---|
| MDL No. | MFCD05662344 |
| MF | C14H9ClF3NO2 |
| MW | 315.67 |
| InChI Key | XPOQHMRABVBWPR-ZDUSSCGKSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 10 mg | 98% | $9 | In Stock | |
| 250 mg | 98% | $24 | In Stock | |
| 1 g | 98% | $46 | In Stock | |
| 5 g | 99% | $161 | In Stock | |
| 10 g | 99% | $307 | In Stock |
Product Information
Efavirenz is 1,4-dihydro-2H-3,1-benzoxazin-2-one with a cyclopropylethynyl and trifluoromethyl group (S configuration) at the 4-position and a chlorine atom at the 6-position. It is a non-nucleoside reverse transcriptase inhibitor effective against HIV, used in combination therapy with other antiretrovirals. It functions as a HIV-1 reverse transcriptase inhibitor and antiviral drug. It is classified as a benzoxazine, acetylenic compound, organochlorine compound, organofluorine compound, and cyclopropane.
| CAS No. | 154598-52-4 |
|---|---|
| Product Name | Efavirenz |
Associated Conditions
triple-negative breast cancer·malaria·pancreatic carcinoma·viral disease·AIDS·
* The information provided here is compiled from public sources and is for reference only.
